137 related articles for article (PubMed ID: 37342035)
1. Locoregional Recurrence Patterns in Patients With Different Molecular Subtypes of Breast Cancer.
Cheun JH; Kim HK; Moon HG; Han W; Lee HB
JAMA Surg; 2023 Aug; 158(8):841-852. PubMed ID: 37342035
[TBL] [Abstract][Full Text] [Related]
2. Age-Related Incidence and Peak Occurrence of Contralateral Breast Cancer.
Kim H; Yoon TI; Kim S; Lee SB; Kim J; Chung IY; Ko BS; Lee JW; Son BH; Lee YJ; Gwark S; Kim HJ
JAMA Netw Open; 2023 Dec; 6(12):e2347511. PubMed ID: 38100108
[TBL] [Abstract][Full Text] [Related]
3. Clinical Course and Predictors of Subsequent Recurrence and Survival of Patients With Ipsilateral Breast Tumor Recurrence.
Baek SY; Kim J; Chung IY; Ko BS; Kim HJ; Lee JW; Son BH; Ahn SH; Lee SB
Cancer Control; 2022; 29():10732748221089412. PubMed ID: 35414226
[TBL] [Abstract][Full Text] [Related]
4. Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment.
Jwa E; Shin KH; Kim JY; Park YH; Jung SY; Lee ES; Park IH; Lee KS; Ro J; Kim YJ; Kim TH
Cancer Res Treat; 2016 Oct; 48(4):1363-1372. PubMed ID: 26910473
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ.
Tamura N; Tsuda H; Yoshida M; Hojo T; Akashi-Tanaka S; Kinoshita T; Sugihara K
Breast Cancer; 2016 May; 23(3):510-8. PubMed ID: 25666939
[TBL] [Abstract][Full Text] [Related]
6. Is repeat breast conservation possible for small ipsilateral breast cancer recurrence?
Li Y; Li WW; Yuan L; Xu B
Cancer; 2022 Nov; 128(22):3919-3928. PubMed ID: 36128621
[TBL] [Abstract][Full Text] [Related]
7. Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer: A Post Hoc Analysis of the TAILORx Randomized Clinical Trial.
Kantor O; King TA; Freedman RA; Mayer EL; Chavez-MacGregor M; Korde LA; Sparano JA; Mittendorf EA
JAMA Surg; 2023 Jun; 158(6):583-591. PubMed ID: 37043210
[TBL] [Abstract][Full Text] [Related]
8. Second invasive breast cancers in patients treated with breast-conserving therapy.
Wang J; Tang H; Yin K; Li X; Xie X; Hughes KS
Eur J Surg Oncol; 2021 Oct; 47(10):2492-2498. PubMed ID: 34134902
[TBL] [Abstract][Full Text] [Related]
9. Increased Mortality with Repeat Lumpectomy Alone After Ipsilateral Breast Tumor Recurrence.
Su Y; Guo R; Xue J; Chi Y; Chi W; Wang J; Yang B; Wu J
Oncologist; 2019 Sep; 24(9):e818-e827. PubMed ID: 30842240
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial.
Vrieling C; van Werkhoven E; Maingon P; Poortmans P; Weltens C; Fourquet A; Schinagl D; Oei B; Rodenhuis CC; Horiot JC; Struikmans H; Van Limbergen E; Kirova Y; Elkhuizen P; Bongartz R; Miralbell R; Morgan DA; Dubois JB; Remouchamps V; Mirimanoff RO; Hart G; Collette S; Collette L; Bartelink H;
JAMA Oncol; 2017 Jan; 3(1):42-48. PubMed ID: 27607734
[TBL] [Abstract][Full Text] [Related]
11. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and prognosis of patients with ipsilateral breast tumor recurrence after breast conservation therapy].
Sun GY; Wang SL; Tang Y; Jin J; Song YW; Liu YP; Wang WH; Fang H; Chen SY; Ren H; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):352-358. PubMed ID: 29860762
[No Abstract] [Full Text] [Related]
13. Long-term survival outcomes of repeat lumpectomy for ipsilateral breast tumor recurrence: a propensity score-matched analysis.
Baek SY; Kim J; Chung IY; Ko BS; Kim HJ; Lee JW; Son BH; Ahn SH; Lee SB
Breast Cancer Res Treat; 2021 Jan; 185(1):155-164. PubMed ID: 32935236
[TBL] [Abstract][Full Text] [Related]
14. Young age is associated with ipsilateral breast tumor recurrence after breast conserving surgery and radiation therapy in patients with HER2-positive/ER-negative subtype.
Kim HJ; Han W; Yi OV; Shin HC; Ahn SK; Koh BS; Moon HG; You JH; Son BH; Ahn SH; Noh DY
Breast Cancer Res Treat; 2011 Nov; 130(2):499-505. PubMed ID: 21853352
[TBL] [Abstract][Full Text] [Related]
15. Contralateral Breast Cancer Risk in Women with Ductal Carcinoma In Situ: Is it High Enough to Justify Bilateral Mastectomy?
Miller ME; Muhsen S; Olcese C; Patil S; Morrow M; Van Zee KJ
Ann Surg Oncol; 2017 Oct; 24(10):2889-2897. PubMed ID: 28766208
[TBL] [Abstract][Full Text] [Related]
16. Incidence of isolated local breast cancer recurrence and contralateral breast cancer: A systematic review.
Spronk I; Schellevis FG; Burgers JS; de Bock GH; Korevaar JC
Breast; 2018 Jun; 39():70-79. PubMed ID: 29621695
[TBL] [Abstract][Full Text] [Related]
17. Omission of axillary surgery for ipsilateral breast tumor recurrence with negative nodes after previous breast-conserving surgery: is it oncologically safe?
Qu FL; Lin CJ; Liu ZB; Cao AY; Wu J; Liu GY; Yu KD; Di GH; Li JJ; Shao ZM
Breast Cancer Res Treat; 2022 Nov; 196(1):97-109. PubMed ID: 36040640
[TBL] [Abstract][Full Text] [Related]
18. Locoregional recurrence by molecular subtype after multicatheter interstitial accelerated partial breast irradiation: Results from the Pooled Registry Of Multicatheter Interstitial Sites research group.
Anderson BM; Kamrava M; Wang PC; Chen P; Demanes DJ; Hayes JK; Kuske RR
Brachytherapy; 2016; 15(6):788-795. PubMed ID: 27743957
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving Surgery.
Gosset M; Hamy AS; Mallon P; Delomenie M; Mouttet D; Pierga JY; Lae M; Fourquet A; Rouzier R; Reyal F; Feron JG
PLoS One; 2016; 11(8):e0159888. PubMed ID: 27494111
[TBL] [Abstract][Full Text] [Related]
20. Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients.
Lin Y; Yin W; Yan T; Zhou L; Di G; Wu J; Shen Z; Shao Z; Lu J
BMC Cancer; 2009 Sep; 9():342. PubMed ID: 19778431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
